Frisch Financial Group, Inc. Moderna, Inc. Transaction History

Frisch Financial Group, Inc.

  • $333 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022
SELL
$126.46 - $235.05 $112,549 - $209,194
-890 Closed
0 $0
Q4 2021

Feb 09, 2022
SELL
$225.82 - $368.51 $38,389 - $62,646
-170 Reduced 16.04%
890 $226,000
Q3 2021

Nov 15, 2021
BUY
$221.9 - $484.47 $235,214 - $513,538
1,060 New
1,060 $408,000

Others Institutions Holding MRNA

# of Institutions
953
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Frisch Financial Group, Inc. Portfolio

Follow Frisch Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email